Tips for management of refractory ascites: Response and survival are both unpredictable

Digestive Diseases and Sciences

Volumn 48, Issue 3, 2003, Pages 542-550

  Thuluvath, Paul J ^a,b   Bal, Jasdeep S ^a   Mitchell, Sally ^a   Lund, Gunnar ^a   Venbrux, Anthony ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Ascites; Cirrhosis; Liver; TIPS

Indexed keywords

FUROSEMIDE; SPIRONOLACTONE;

ADULT; ARTICLE; ASCITES; DISEASE SEVERITY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PORTAL VEIN BLOOD PRESSURE; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; SURGICAL MORTALITY; SURVIVAL; TREATMENT OUTCOME;

ASCITES; FEMALE; FOLLOW-UP STUDIES; HEPATIC ENCEPHALOPATHY; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PARACENTESIS; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PROSTHESIS FAILURE; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0037341627     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022544917898     Document Type: Article

References (44)

1. Bories P, Garcia Compean G, Michel H, Bourel M, Capron JP, Gauthier A, Lafon J, Levy VG, Pascal JP, Quinton A, et al: The treatment of refractory ascites by the LeVeen shunt. A multicentre controlled trial (57 patients). J Hepatol 3:212-218, 1986
2. Brensing KA, Textor J, Perz J, Schiedermaier P, Raab P, Strunk H, Klehr HU, Kramer HJ, Spengler U, Schild H, Sauerbruch T: Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut 47:288-295, 2000
3. Crenshaw WB, Gordon FD, McEniff NJ, Perry LJ, Hartnell G, Anastopoulos H, Jenkins RL, Lewis WD, Wheeler HG, Clouse ME: Severe ascites: efficacy of the transjugular intrahepatic porto-systemic shunt in treatment. Radiology 200:185-192, 1996
4. Deschenes M, Dufresne MP, Bui B, Fenyves D, Spahr L, Roy L, Lafortune M, Pomier-Layrargues G: Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites. Am J Gastroenterol 94:1361-1365, 1999
5. Franco D, Vons C, Traynor O, de Smadja C: Should portosystemic shunt be considered in the treatment of intractable ascites in cirrhotics? Arch Surg 123:987-991, 1988
6. Lebrec D, Giuily N, Hadengue A, Vilgrain V, Moreau R, Poynard T, Gadano A, Lassen C, Benhamou JP, Erlinger S: Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists. J Hepatol 25:135-144, 1996
7. Martinet JP, Fenyves D, Legault L, Roy L, Dufresne MP, Spahr L, Lafortune M, Pomier-Layrargues G: Treatment of refractory ascites using transjugular intrahepatic porto-systemic shunt. Dig Dis Sci 42:161-166, 1997
8. Nazarian GK, Bjarnason H, Dietz CA Jr, Bernadas CA, Foshager MC, Ferral H, Hunter DW: Refractory ascites: midterm results of treatment with a transjugular intrahepatic portosystemic shunt. Radiology 205:173-180, 1997
9. Rees CJ, Rose JD, Record CO, Day CP, Bassendine MF, James OF, Hudson M: Transjugular intrahepatic portosystemic shunt: a limited role in refractory ascites. Eur J Gastroenterol Hepatol 9:969-973, 1997
10. Rossle M, Ochs A, Gulberg V, Siegerstetter V, Holl J, Deibert P, Olschewski M, Reiser M, Gerbes AL: A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Meal 342:1701-1707, 2000
11. Williams DB, Waugh R, Selby W: Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of refractory ascites. Aust NZ J Med 28:620-626, 1998
12. Fernandez-Seara J, Prieto J, Quiroga J, Zozaya JM, Cobos MA, Rodriguez-Eire JL, Garcia-Plaza A, Leal J: Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure. Gastroenterology 97:1304-1312, 1989
13. Schrier RW, Arroyo V, Bernardi M, Epatein M, Henriksen JH, Rodes J: Peripheral arterial vasodilatation hypothesis: aproposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 8:1151-1157, 1988
14. Wong F, Liu P, Allidina Y, Blendis LM: Pattern of sodium handling and its consequences in pre-ascitic cirrhosis. Gastroenterology 108:1820-1827, 1995
15. Koepke JP, Jones S, DiBona GF: Renal nerves mediate blunted natriuresis to atrial natriuretic peptide in cirrhotic rats. Am J Physiol 252:R1019-R1023, 1987
16. Campbell V, Greig P, Cranford J, Langer B, Silverman M, Blendis L: A comparison of acute reversible pre and post-sinusoidal portal hypertension on salt and water retention in the dog. Hepatology 2:54-58, 1982
17. Morali G, Sniderman K, Deitel KM, Tobe S, Witt-Sullivan H, Simon M, Heathcote J, Blendis LM: Is sinusoidal portal hypertension a necessary factor for the development of hepatic ascites. J Hepatol 16:249-250, 1992
18. Wong F, Blendis L: Transjugular intrahepatic portosystemic shunt for refractory ascites: tipping the sodium balance. Hepatology 22:358-364, 1995
19. Stanley MM, Ochi S, Lee KK, Nemchausky BA, Greenlee HB, Allen JI, Allen MJ, Baum RA, Gadacz TR, Camara DS: Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. N Engl J Med 321:1632-1638, 1989
20. Bruno S, Borzio M, Romagnoni M, Battezzati PM, Rossi S, Chiesa A, Podda M: Comparison of spontaneous ascites filtration and reinfusion with total paracentesis with intravenous albumin infusion in cirrhotic patients with tense ascites: a randomized study. BMJ 304:1655-1658, 1992
21. Cadranel JF, Gargot D, Grippon P, Lunel F, Bernard B, Valla D, Opolon P: Spontaneous dialytic ultra filtration with intraperitoneal infusion of the concentrate versus large paracentesis in cirrhotic patients with intactable ascites: a randomized study. Intl J Artif Organs 15:432-435, 1992
22. Smart HL, Triger DR: A randomized prospective trial comparing daily paracentesis and intravenous albumin with recirculation in diuretic refractory ascites. J Hepatol 10:191-197, 1990
23. LeVeen HH, Wapnick S, Grosberg S, Kinney MJ: Further experience with peritoneovenous shunt for ascites. Ann Surg 184:574-581, 1976
24. Smadga C, Franco D: The LeVeen shunt in the elective treatment of intractable ascites in cirrhosis: a prospective study on patients. Ann Surg 201:488-493, 1985
25. Elcheroth J, Vons C, Franco D: Role of surgical therapy in the management of intractable ascites. World J Surg 18:240-245, 1994
26. Gines P, Arroyo V, Quintero E, Planas R, Bory F, Cabrera J, Rimola A, Viver J, Camps J, Jimenez W, Mastai R, Gaya J, Rodes J: Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Gastroenterology 93:234-241, 1987
27. Gines P, Arroyo V, Vargas V, Planas R, Casafont F, Panes J, Hoyos M, Viladomiu L, Rimola A, Morillas R, Salmeron JM, Gines A, Esteban R, Rodes J: Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med 325:829-835, 1991
28. Rossle M, Haag K, Ochs A, Sellinger M, Noldge G, Perarnau J-M, Berger E, Blum U, Gabelmann A, Havenstein K, Langer M, Gerok W: The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 330:165-171, 1994
29. Wong F, Sniderman K, Liu P, Allidina Y, Sherman M, Blendis L: The mechanism of initial natriuresis after transjugular intrahepatic portosystemic shunt. Gastroenterology 112:899-907, 1997
30. Gerbes AL, Gulberg V, Waggershauser T, Holl J, Reiser M: Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: comparison of patients with ascites, with refractory ascites, or without ascites. Hepatology 28:683-688, 1998
31. Quiroga J, Sangro B, Nunez M, Bilbao I, Longo J, Garcia-Villarreal L, Zozaya JM, Betes M, Herrero JI, Prieto J: Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites-effect on clinical, renal, humoral, and hemodynamic parameters. Hepatology 21:986-994, 1995
32. Guevara M, Gines P, Bandi JC, Gilabert R, Sort P, Jimenez W, Garcia-Pagan JC, Bosch J, Arroyo V, Rodes J: Transjugular intrahepatic portal-systemic shunt in hepatorenal syndrome: effect on renal function and vasoactive systems. Hepatology 28:416-422, 1998
33. Jalan R, Redhead DN, Thomas HW, Henderson N, O'Rourke K, Dillon JF, Williams BC, Hayes PC: Mechanisms of changes in renal handling following transjugular intrahepatic portosystemic stent-shunt (TIPSS). Eur J Gastroenterol Hepatol 8 (11): 1111-1116, 1996
34. Martinet JP, Legault L, Cernacek P, Roy L, Dufresne MP, Spahr L, Fenyves D, Pomier-Layrargues G: Changes in plasma endothelin-1 and Big endothelin- 1 induced by transjugular intrahepatic portosystemic shunts in patients with cirrhosis and refractory ascites. J Hepatol 25:700-706, 1996
35. Somberg KA, Lake JR, Tomlanovich SJ, LaBerge JM, Bass NM: Transjugular intrahepatic portosystemic shunt for refractory ascites: assessment of clinical and humoral response and renal function. Hepatology 21:709-716, 1995
36. Ochs A, Rossle M, Haag K, Hauenstein K-H, Deibert P, Siegerstetter V, Huonker M, Langer M, Blum HE: The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 332:1192-1197, 1995
37. LaBerge JM, Ring EJ, Gordon RL, Lake JR, Doherty MM, Somberg KA, Roberts JP, Ascher NL: Creation of transjugular intrahepatic portosystemic shunts with the Wallstent endoprosthesis: results in 100 patients. Radiology 187:413-420, 1993
38. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R: Transection of the oesophagus for oesophageal varices. Br J Surg 60:646-649, 1973
39. Ferral H, Bjarnason H, Wegryn SA, Rengel GJ, Nazarian GK, Rank JM, Tadavarthy SM, Hunter DW, Castaneda-Zuniga WR: Refractory ascites - early experience in treatment with transjugular intrahepatic portosystemic shunt. Radiology 189:795-801, 1993
40. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC: A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31:864-871, 2000
41. Papatheodoridis GV, Goulis J, Leandro G, Patch D, Burroughs AK: Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal bleeding: a meta-analysis. Hepatology 30:612-622, 1999
42. Sanyal AJ, Freeman AM, Shiffman ML, Purdum PP, Luketic VA, Cheatham AK: Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective study. Hepatology 20:46-55, 1994
43. Nolte W, Wiltfang J, Schindler C, Munke H, Unterberg K, Zumhasch U, Figulla HR, Werner G, Hartmann H, Ramadori G: Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations. Hepatology 28:1215-1225, 1998
44. Pomier-Layrargues G: TIPS and hepatic encephalopathy. Semin Liver Dis 16:315-320, 1996